Article

1 Iconography
Access to the text (HTML) Access to the text (HTML)
PDF Access to the PDF text
Advertising


Access to the full text of this article requires a subscription.
  • If you are a subscriber, please sign in 'My Account' at the top right of the screen.

  • If you want to subscribe to this journal, see our rates



Therapies
Sous presse. Epreuves corrigées par l'auteur. Disponible en ligne depuis le mercredi 11 mars 2020
Doi : 10.1016/j.therap.2020.02.015
Received : 16 July 2019 ;  accepted : 13 February 2020
Une lentiginose aggravée par la capécitabine
Capecitabine aggravating lentiginosis
 

Safa Idoudi , Lobna Boussofara, Marwen Belkahla, Nadia Ghariani Fetoui, Najet Ghariani, Colandane Belajouza, Mohamed Denguezli
 Département de dermatologie, hôpital Farhat Hached, 4000 Sousse, Tunisie 

Auteur correspondant.

Mots clés : Capécitabine, Hyperpigmentation, Syndrome main-pied, Lentigines, Peutz-Jeghers

Keywords : Capecitabine, Hyperpigmentation, Hand-foot syndrome, Lentigine, Peutz-Jeghers



 Cas déclaré le 25 juillet 2019, service de pharmacovigilance, faculté de medicine Ibn Jazzar (Sousse, Tunisie) no 98/2019.



© 2020  Société française de pharmacologie et de thérapeutique@@#104156@@
EM-CONSULTE.COM is registrered at the CNIL, déclaration n° 1286925.
As per the Law relating to information storage and personal integrity, you have the right to oppose (art 26 of that law), access (art 34 of that law) and rectify (art 36 of that law) your personal data. You may thus request that your data, should it be inaccurate, incomplete, unclear, outdated, not be used or stored, be corrected, clarified, updated or deleted.
Personal information regarding our website's visitors, including their identity, is confidential.
The owners of this website hereby guarantee to respect the legal confidentiality conditions, applicable in France, and not to disclose this data to third parties.
Close
Article Outline